Browsing by Author Mylonakis, N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 14 of 14
TitleAuthor(s)Issue date???itemlist.???
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group studySkarlos, D. V.; Aravantinos, G.; Kosmidis, P.; Pavlidis, N.; Gennatas, K.; Beer, M.; Mylonakis, N.; Makrantonakis, P.; Klouvas, G.; Karpathios, S.; Linardou, H.; Konstantaras, C.; Fountzilas, G.24-Nov-2015-
Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective]Tsavaris, N.; Primikirios, N.; Mylonakis, N.; Varouchakis, G.; Dosios, T.; Pavlidis, N.; Skarlos, D.; Tasopoulos, T.; Dritsas, J.; Kosmidis, P.24-Nov-2015-
Combination chemotherapy with cisplatin-vinblastine in malignant mesotheliomaTsavaris, N.; Mylonakis, N.; Karvounis, N.; Bacoyiannis, C.; Briasoulis, E.; Skarlos, D.; Pavlidis, N.; Stamatelos, G.; Kosmidis, P.24-Nov-2015-
Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancerSamantas, E.; Skarlos, D. V.; Pectasides, D.; Nicolaides, P.; Kalofonos, H.; Mylonakis, N.; Vardoulakis, T.; Kosmidis, P.; Pavlidis, N.; Fountzilas, G.24-Nov-2015-
Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology GroupKosmidis, P.; Mylonakis, N.; Dimopoulos, A.; Pavlidis, N.; Fountzilas, G.; Samantas, E.; Dimitriadis, K.; Kalophonos, C.; Tsavdaridis, D.; Skarlos, D.24-Nov-2015-
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group StudyFountzilas, G.; Polichronis, A.; Katsohis, K.; Gennatas, K.; Toussis, D.; Skarlos, D.; Kosmidis, P.; Vassilaros, S.; Semoglou, C.; Giannakakis, T.; Fahantidis, E.; Klouvas, G.; Tsavaris, N.; Konstantaras, C.; Makrantonakis, P.; Kolotas, C.; Zamboglou, N.; Tsiliakos, S.; Hainoglou, D.; Mylonakis, N.; Pavlidis, N.24-Nov-2015-
Docetaxel in combination with dacarbazine in patients with advanced melanomaBafaloukos, D.; Aravantinos, G.; Fountzilas, G.; Stathopoulos, G.; Gogas, H.; Samonis, G.; Briasoulis, E.; Mylonakis, N.; Skarlos, D. V.; Kosmidis, P.24-Nov-2015-
Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG)Nicolaides, C.; Klouvas, G.; Fountzilas, G.; Athanassiadis, A.; Skarlos, D.; Samantas, E.; Kosmidis, P.; Mylonakis, N.; Pavlidis, N.24-Nov-2015-
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group studyBriasoulis, E.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Xiros, N.; Aravantinos, G.; Samantas, E.; Kalofonos, H.; Makatsoris, T.; Mylonakis, N.; Papakostas, P.; Skarlos, D.; Varthalitis, I.; Pavlidis, N.24-Nov-2015-
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)Kosmidis, P.; Mylonakis, N.; Skarlos, D.; Samantas, E.; Dimopoulos, M.; Papadimitriou, C.; Kalophonos, C.; Pavlidis, N.; Nikolaidis, C.; Papaconstantinou, C.; Fountzilas, G.24-Nov-2015-
Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized studyKosmidis, P.; Mylonakis, N.; Fountzilas, G.; Samantas, E.; Athanassiadis, A.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II studyKosmidis, P. A.; Mylonakis, N.; Fountzilas, G.; Samantas, E.; Athanasiadis, A.; Andreopoulou, E.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer: a Hellenic Cooperative Oncology Group (HeCOG) studyKalofonos, H. P.; Nicolaides, C.; Samantas, E.; Mylonakis, N.; Aravantinos, G.; Dimopoulos, M. A.; Gennatas, C.; Kouvatseas, G.; Giannoulis, E.; Dervenis, C.; Basdanis, G.; Pavlidis, N.; Androulakis, I.; Fountzilas, G.24-Nov-2015-
A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology GroupKosmidis, P.; Mylonakis, N.; Fountzilas, G.; Pavlidis, N.; Samantas, E.; Karabelis, A.; Kattis, K.; Skarlos, D.24-Nov-2015-